Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AMPH

Amphastar Pharmaceuticals Inc

Dec 01 • 04:00PM ET

57.92

Dollar change +1.60
Percentage change 2.84	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	22.61	EPS (ttm)	2.56	Insider Own	25.52%	Shs Outstand	48.11M	Perf Week	1.85%
Market Cap	2.77B	Forward P/E	15.63	EPS next Y	3.71	Insider Trans	-2.05%	Shs Float	35.68M	Perf Month	27.46%
Income	135.29M	PEG	0.90	EPS next Q	0.91	Inst Own	67.88%	Short Float / Ratio	8.10% / 6.28	Perf Quarter	6.22%
Sales	601.31M	P/S	4.61	EPS this Y	70.34%	Inst Trans	-2.16%	Short Interest	2.89M	Perf Half Y	24.03%
Book/sh	12.43	P/B	4.66	EPS next Y	10.42%	ROA	11.91%	Target Price	66.50	Perf Year	96.41%
Cash/sh	6.39	P/C	9.06	EPS next 5Y	25.00%	ROE	24.59%	52W Range	27.58 - 67.66	Perf YTD	106.71%
Dividend	-	P/FCF	19.85	EPS past 5Y	87.41%	ROI	10.71%	52W High	-14.40%	Beta	0.93
Dividend %	-	Quick Ratio	1.68	Sales past 5Y	15.95%	Gross Margin	53.06%	52W Low	110.01%	ATR	2.04
Employees	1615	Current Ratio	2.10	Sales Q/Q	50.30%	Oper. Margin	30.52%	RSI (14)	68.20	Volatility	3.83% 4.11%
Optionable	Yes	Debt/Eq	1.13	EPS Q/Q	203.56%	Profit Margin	22.50%	Rel Volume	0.99	Prev Close	56.32
Shortable	Yes	LT Debt/Eq	1.12	Earnings	Nov 08 AMC	Payout	0.00%	Avg Volume	460.22K	Price	57.92
Recom	2.00	SMA20	8.88%	SMA50	18.49%	SMA200	22.69%	Volume	456,973	Change	2.84%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-17-23	Initiated	BofA Securities	Neutral	$63
Jul-25-23	Resumed	Jefferies	Buy	$70
Oct-21-22	Resumed	Jefferies	Buy	$36
Jul-29-22	Initiated	CapitalOne	Overweight	$44
Jan-07-22	Upgrade	Piper Sandler	Neutral → Overweight	$21 → $28
Jan-08-21	Downgrade	Wells Fargo	Overweight → Equal Weight	$21
Oct-05-20	Upgrade	Northland Capital	Market Perform → Outperform	$24
May-01-20	Initiated	Northland Capital	Outperform	$23
Mar-13-19	Downgrade	Piper Jaffray	Overweight → Neutral	$24 → $23
Mar-13-19	Downgrade	Needham	Buy → Hold
Aug-10-18	Reiterated	Needham	Buy	$24 → $22
Mar-13-18	Reiterated	Needham	Buy	$23 → $24
Dec-01-17	Reiterated	Needham	Buy	$20 → $23
Nov-09-17	Downgrade	Raymond James	Outperform → Mkt Perform
Sep-27-17	Reiterated	Needham	Buy	$18 → $20
Mar-14-17	Downgrade	Raymond James	Strong Buy → Outperform
Aug-09-16	Reiterated	Needham	Buy	$20 → $22
May-10-16	Reiterated	Needham	Buy	$21 → $20
Feb-19-16	Initiated	Wells Fargo	Outperform
Jun-19-15	Reiterated	Needham	Buy	$17 → $21

Show Previous Ratings

Nov-30-23 06:13PM	This Biotech Stock Nears A Buy Point After 200% Profit Growth (Investor's Business Daily)
Nov-29-23 12:01PM	The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks (Investor's Business Daily)
09:30AM	Amphastar (AMPH) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
Nov-22-23 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Amphastar (AMPH) (Zacks)
Nov-21-23 01:03AM	Insider Sell Alert: Director Richard Prins Sells 4,000 Shares of Amphastar Pharmaceuticals Inc ... (GuruFocus.com)
04:20PM	Loading…
Nov-20-23 04:20PM	Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference (ACCESSWIRE)
Nov-17-23 11:04AM	Insider Sell: CFO William Peters Sells Shares of Amphastar Pharmaceuticals Inc (GuruFocus.com)
Nov-16-23 05:10AM	Insider Sell: Director Richard Prins Sells 5,000 Shares of Amphastar Pharmaceuticals Inc (AMPH) (GuruFocus.com)
Nov-13-23 09:30AM	Wall Street Analysts See Amphastar (AMPH) as a Buy: Should You Invest? (Zacks)
Nov-10-23 03:43PM	Amphastar Pharmaceuticals Stock Earns Composite Rating Upgrade (Investor's Business Daily)
01:15PM	Plenty Of IBD 50 Companies' Earnings Impress, And Some Remain Actionable (Investor's Business Daily)
Nov-09-23 04:05PM	Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference (ACCESSWIRE) +15.39%
01:27PM	Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2023 Earnings Call Transcript (Insider Monkey)
08:38AM	Q3 2023 Amphastar Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
05:42AM	Amphastar: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
Nov-08-23 04:05PM	Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023 (ACCESSWIRE)
Nov-01-23 04:10PM	Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023 (ACCESSWIRE)
Oct-31-23 05:45PM	Amphastar Pharmaceuticals (AMPH) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
06:43AM	Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies (Zacks)
Oct-30-23 05:50PM	Amphastar Pharmaceuticals (AMPH) Laps the Stock Market: Here's Why (Zacks)
Oct-23-23 05:50PM	Amphastar Pharmaceuticals (AMPH) Rises As Market Takes a Dip: Key Facts (Zacks)
Oct-16-23 05:50PM	Amphastar Pharmaceuticals (AMPH) Laps the Stock Market: Here's Why (Zacks)
Oct-10-23 09:40AM	Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year? (Zacks)
Oct-09-23 05:50PM	Amphastar Pharmaceuticals (AMPH) Rises Higher Than Market: Key Facts (Zacks)
Oct-02-23 05:50PM	Amphastar Pharmaceuticals (AMPH) Stock Sinks As Market Gains: What You Should Know (Zacks)
Sep-25-23 05:50PM	Amphastar Pharmaceuticals (AMPH) Outpaces Stock Market Gains: What You Should Know (Zacks)
Sep-19-23 05:50PM	Amphastar Pharmaceuticals (AMPH) Dips More Than Broader Markets: What You Should Know (Zacks)
Sep-14-23 09:30AM	Should You Invest in Amphastar (AMPH) Based on Bullish Wall Street Views? (Zacks)
Sep-13-23 05:50PM	Amphastar Pharmaceuticals (AMPH) Stock Sinks As Market Gains: What You Should Know (Zacks)
12:37AM	Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes (ACCESSWIRE)
04:05PM	Loading…
Sep-11-23 04:05PM	Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes (ACCESSWIRE)
Sep-09-23 01:01AM	Insider Sell: CFO, EVP & Treasurer William Peters Sells 60,743 Shares of Amphastar ... (GuruFocus.com)
Aug-31-23 04:05PM	Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference (ACCESSWIRE)
Aug-18-23 01:54PM	Amphastar Pharma (AMPH) Stock Skyrockets 89% YTD: Here's Why (Zacks)
Aug-14-23 07:01AM	Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Dr. Reddy's Laboratories and Teva Pharmaceutical (Zacks)
Aug-11-23 12:45PM	Is Amphastar (AMPH) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
10:33AM	3 Generic Drug Stocks to Watch Amid Improving Market Prospects (Zacks)
09:40AM	Is Amphastar Pharmaceuticals (AMPH) Stock Outpacing Its Medical Peers This Year? (Zacks)
Aug-10-23 09:15AM	Dr. Reddy's Laboratories Ltd (RDY) Hits Fresh High: Is There Still Room to Run? (Zacks) -14.16%
Aug-09-23 07:18AM	Q2 2023 Amphastar Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-08-23 08:30PM	Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates (Zacks)
07:19PM	Amphastar: Q2 Earnings Snapshot (AP Finance)
04:05PM	Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023 (ACCESSWIRE)
Aug-02-23 04:10PM	Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023 (ACCESSWIRE)
Jul-28-23 08:02AM	Dr. Reddy's (RDY) Q1 Earnings and Revenues Beat Estimates (Zacks)
Jul-26-23 05:50PM	Amphastar Pharmaceuticals (AMPH) Dips More Than Broader Markets: What You Should Know (Zacks)
12:00PM	Amphastar Pharmaceuticals (AMPH) is a Great Momentum Stock: Should You Buy? (Zacks)
Jul-25-23 07:42AM	Amphastar (AMPH) to Report Q2 Earnings: What's in the Cards? (Zacks)
Jul-23-23 08:27AM	Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today? (Simply Wall St.)
Jul-20-23 05:50PM	Amphastar Pharmaceuticals (AMPH) Gains As Market Dips: What You Should Know (Zacks)
05:01AM	The Zacks Analyst Blog Highlights Abercrombie & Fitch, InterDigital, Shake Shack, Amphastar and PGT Innovations (Zacks)
Jul-19-23 09:10AM	5 Must-Buy High-Flying Mid-Caps to Enhance Your Portfolio (Zacks)
Jul-17-23 08:40PM	BridgeBio Pharma (BBIO) Moves 75.9% Higher: Will This Strength Last? (Zacks)
Jul-14-23 05:50PM	Amphastar Pharmaceuticals (AMPH) Gains As Market Dips: What You Should Know (Zacks)
Jul-12-23 12:45PM	Amphastar (AMPH) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
Jul-11-23 09:40AM	Is Align Technology (ALGN) Outperforming Other Medical Stocks This Year? (Zacks)
Jul-10-23 08:12AM	Zacks.com featured highlights include PDD Holdings, Amphastar Pharmaceuticals and Suzano (Zacks)
Jul-07-23 08:41AM	3 Profitable Stocks Worth Investing in Using Net Income Ratio (Zacks)
Jul-05-23 12:00PM	Amphastar Pharmaceuticals (AMPH) Is Up 0.54% in One Week: What You Should Know (Zacks)
Jun-30-23 04:05PM	Amphastar Pharmaceuticals Completes Acquisition of BAQSIMI from Lilly (ACCESSWIRE)
01:21PM	After Big Tech's Massive Gains, Are Health Care Stocks Next To Lead? Here's What IBD 50 Shows (Investor's Business Daily)
Jun-26-23 12:45PM	3 Reasons Growth Investors Will Love Amphastar (AMPH) (Zacks)
Jun-23-23 09:40AM	Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year? (Zacks)
Jun-21-23 08:00PM	AMPH: Raising target price to $62.00 (Argus Research)
Jun-17-23 09:13AM	Is Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Latest Stock Performance A Reflection Of Its Financial Health? (Simply Wall St.)
Jun-08-23 12:45PM	Here is Why Growth Investors Should Buy Amphastar (AMPH) Now (Zacks)
Jun-07-23 09:40AM	Is Amphastar Pharmaceuticals (AMPH) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jun-05-23 08:23AM	Zacks.com featured highlights include Tecnoglass, Amphastar Pharmaceuticals, Turkcell Iletisim Hizmetleri, and Copa Holdings (Zacks)
Jun-02-23 07:41AM	4 Solid Profitable Stocks to Invest in Using Net Income Ratio (Zacks)
Jun-01-23 02:31PM	IBD 50 Stock Hits All-Time High, And 44% EPS Growth Expected (Investor's Business Daily)
May-31-23 04:15PM	Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference (ACCESSWIRE)
May-28-23 08:42AM	Amphastar Pharmaceuticals (NASDAQ:AMPH) shareholders have earned a 22% CAGR over the last five years (Simply Wall St.)
May-24-23 04:34AM	Zacks Industry Outlook Highlights Amphastar, Dr. Reddy's and Teva Pharmaceutical (Zacks)
May-23-23 12:45PM	Looking for a Growth Stock? 3 Reasons Why Amphastar (AMPH) is a Solid Choice (Zacks)
08:01AM	3 Generic Drug Stocks to Watch Amid Macro Headwinds (Zacks)
May-22-23 09:40AM	Is Amphastar Pharmaceuticals (AMPH) Outperforming Other Medical Stocks This Year? (Zacks)
08:50AM	Amphastar (AMPH) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
May-11-23 06:05AM	Amphastar Pharmaceuticals First Quarter 2023 Earnings: EPS: US$0.54 (vs US$0.50 in 1Q 2022) (Simply Wall St.)
May-10-23 06:12AM	Q1 2023 Amphastar Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +13.04%
May-09-23 05:35PM	Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates (Zacks)
04:05PM	Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2023 (ACCESSWIRE)
May-03-23 04:30PM	Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2023 (ACCESSWIRE)
Apr-26-23 08:00PM	AMPH: Lowering target price to $42.00 (Argus Research)
09:40AM	Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year? (Zacks)
Apr-24-23 10:25AM	Eli Lilly Divests Low Blood Sugar Drug Baqsimi To Amphastar For $500M Cash (Benzinga) -6.68%
07:04AM	UPDATE 2-Eli Lilly to sell low blood sugar drug to Amphastar for around $1 billion (Reuters)
06:45AM	Lilly to Divest BAQSIMI to Amphastar (PR Newswire)
05:53AM	Zacks.com featured highlights Amphastar, Alpha Metallurgical and Riley Exploration (Zacks)
12:00AM	Amphastar Pharmaceuticals Business Update and Hold Conference Call on April 24th, 2023 (ACCESSWIRE)
Apr-21-23 07:11AM	3 Profitable Stocks Worth a Buy Using Net Income Ratio (Zacks)
Apr-20-23 04:53PM	Amphastar Pharmaceuticals Drug Stock Nears All-Time High After 74% Earnings Growth (Investor's Business Daily)
Apr-14-23 12:21PM	Strength Seen in Amphastar (AMPH): Can Its 6.4% Jump Turn into More Strength? (Zacks)
Apr-12-23 04:10PM	Amphastar Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference (ACCESSWIRE)
Apr-11-23 01:45PM	Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Intrinsic Value Is Potentially 38% Above Its Share Price (Simply Wall St.)
Mar-27-23 12:04PM	HCA Healthcare (HCA) Expands in Kansas With a Medical Plaza (Zacks)
Mar-24-23 09:40AM	Is Addus HomeCare (ADUS) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-18-23 09:18AM	Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is favoured by institutional owners who hold 62% of the company (Simply Wall St.)
Mar-13-23 09:55AM	Amphastar Pharmaceuticals (AMPH)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
Mar-09-23 05:30PM	2 Stocks to Buy Now After Powell Flips the Narrative... Again (Zacks)
Mar-08-23 12:11PM	U.S. FDA approves Amphastar Pharma's nasal spray for opioid overdose (Reuters)

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PRINS RICHARD K	Director	Nov 17	Sale	55.86	4,000	223,446	31,895	Nov 20 05:23 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Nov 14	Option Exercise	15.61	59,250	925,028	160,610	Nov 16 04:05 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Nov 14	Sale	55.67	59,250	3,298,475	101,360	Nov 16 04:05 PM
Deflin Gayle	Director	Nov 14	Sale	55.45	4,163	230,838	2,716	Nov 15 04:30 PM
PRINS RICHARD K	Director	Nov 13	Sale	52.50	5,000	262,500	35,895	Nov 15 04:31 PM
Petersen Floyd F.	Director	Nov 01	Sale	45.30	500	22,651	81,833	Nov 02 08:37 PM
Petersen Floyd F.	Director	Oct 02	Sale	45.78	500	22,890	82,333	Oct 03 06:38 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Sep 06	Option Exercise	16.93	56,500	956,795	162,103	Sep 08 04:08 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Sep 06	Sale	51.75	60,743	3,143,195	101,360	Sep 08 04:08 PM
Liawatidewi Yakob	EVP Corp Admin Center	Aug 28	Option Exercise	14.86	28,816	428,095	98,485	Aug 29 06:54 PM
Liawatidewi Yakob	EVP Corp Admin Center	Aug 28	Sale	53.13	28,816	1,530,994	69,669	Aug 29 06:54 PM
PRINS RICHARD K	Director	Aug 18	Sale	52.50	2,000	105,006	40,895	Aug 21 04:05 PM
ZASLOFF MICHAEL A	Director	Aug 15	Sale	57.22	12,759	730,025	33,826	Aug 16 08:23 PM
PRINS RICHARD K	Director	Aug 15	Sale	57.39	4,163	238,911	42,895	Aug 16 08:22 PM
Zhou Rong	EVP, Production Center	Jun 20	Option Exercise	11.33	9,651	109,346	112,341	Jun 21 05:05 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Jun 15	Option Exercise	19.79	36,868	729,618	142,471	Jun 20 04:01 PM
Zhou Rong	EVP, Production Center	Jun 15	Option Exercise	14.64	19,377	283,672	102,690	Jun 20 04:05 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Jun 15	Sale	50.85	36,868	1,874,790	105,603	Jun 20 04:01 PM
Zhou Rong	EVP, Production Center	Jun 15	Sale	51.79	5,000	258,946	96,888	Jun 20 04:05 PM
Zhou Rong	EVP, Production Center	Jun 13	Option Exercise	14.40	5,000	72,000	93,313	Jun 14 05:36 PM
Zhou Rong	EVP, Production Center	Jun 13	Sale	48.24	5,000	241,200	88,313	Jun 14 05:36 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Jun 02	Option Exercise	13.35	11,000	146,850	116,603	Jun 05 05:06 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Jun 02	Sale	46.35	11,000	509,859	105,603	Jun 05 05:06 PM
Lee Howard	Director	Jun 01	Option Exercise	16.69	16,679	278,373	159,618	Jun 05 04:18 PM
Lee Howard	Director	Jun 01	Sale	45.02	16,679	750,960	142,939	Jun 05 04:18 PM
Zhou Rong	EVP, Production Center	May 18	Option Exercise	14.40	10,000	144,000	97,598	May 19 06:36 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	May 18	Option Exercise	13.35	10,500	140,175	115,648	May 22 06:49 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	May 18	Sale	44.35	10,500	465,675	105,148	May 22 06:49 PM
Zhou Rong	EVP, Production Center	May 18	Sale	44.20	10,000	442,050	87,598	May 19 06:36 PM
Deflin Gayle	Director	May 18	Sale	44.01	4,519	198,888	4,163	May 19 06:30 PM
Petersen Floyd F.	Director	May 17	Sale	43.13	5,000	215,655	80,117	May 18 04:52 PM
PRINS RICHARD K	Director	May 15	Option Exercise	16.69	5,000	83,450	49,342	May 16 07:59 PM
ZASLOFF MICHAEL A	Director	May 15	Sale	42.18	7,500	316,335	43,869	May 16 08:01 PM
PRINS RICHARD K	Director	May 15	Sale	43.50	5,000	217,502	44,342	May 16 07:59 PM
Deflin Gayle	Director	May 15	Sale	43.15	1,500	64,728	8,682	May 17 04:05 PM
PRINS RICHARD K	Director	May 12	Option Exercise	16.69	5,000	83,450	52,342	May 16 07:59 PM
PRINS RICHARD K	Director	May 12	Sale	42.06	5,000	210,322	47,342	May 16 07:59 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Apr 17	Option Exercise	13.35	5,632	75,187	110,780	Apr 18 08:07 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Apr 17	Sale	42.35	5,632	238,515	105,148	Apr 18 08:07 PM
Liawatidewi Yakob	EVP Corp Admin Center	Apr 13	Option Exercise	20.23	11,494	232,524	80,709	Apr 14 05:50 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Apr 13	Option Exercise	13.35	4,868	64,988	110,016	Apr 14 05:48 PM
Liawatidewi Yakob	EVP Corp Admin Center	Apr 13	Sale	41.56	11,494	477,748	69,215	Apr 14 05:50 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Apr 13	Sale	42.35	4,868	206,160	105,148	Apr 14 05:48 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Apr 10	Option Exercise	13.35	10,032	133,927	115,180	Apr 12 05:21 PM
Liawatidewi Yakob	EVP Corp Admin Center	Apr 10	Option Exercise	20.23	5,000	101,150	74,215	Apr 12 05:22 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Apr 10	Sale	40.35	10,032	404,791	105,148	Apr 12 05:21 PM
Liawatidewi Yakob	EVP Corp Admin Center	Apr 10	Sale	40.00	5,000	200,000	69,215	Apr 12 05:22 PM
Petersen Floyd F.	Director	Apr 03	Sale	37.72	491	18,519	85,117	Apr 04 07:12 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Mar 15	Option Exercise	14.95	6,688	99,986	131,227	Mar 17 07:03 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Mar 15	Sale	36.43	12,776	465,472	118,451	Mar 17 07:03 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Mar 01	Option Exercise	11.33	10,974	124,335	111,588	Mar 03 04:47 PM
PETERS WILLIAM J	CFO, EVP & Treasurer	Mar 01	Sale	36.33	10,974	398,685	100,614	Mar 03 04:47 PM
Petersen Floyd F.	Director	Mar 01	Sale	36.70	500	18,349	85,608	Mar 02 07:33 PM
Petersen Floyd F.	Director	Feb 01	Sale	30.35	500	15,176	86,108	Feb 02 04:44 PM
Petersen Floyd F.	Director	Jan 03	Sale	27.94	500	13,971	86,608	Jan 04 04:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMPH

Amphastar Pharmaceuticals Inc

Upgrade your FINVIZ experience